NeoGenomics (NEO) Soars 7.2%: Is Further Upside Left in the Stock?

NeoGenomics (NEO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zacks Investment Research • Jun 19, 2026

NeoGenomics Announces Pricing of Offering of $275 Million Convertible Senior Notes

FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics Announces Pricing of Offering of $275 Million Convertible Senior Notes.

Business Wire • Jun 17, 2026

NeoGenomics Announces Proposed Offering of $275 Million Convertible Senior Notes

FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics Announces Proposed Offering of $275 Million Convertible Senior Notes.

Business Wire • Jun 15, 2026

NeoGenomics to Present New Research at ASCO Annual Meeting 2026

FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics will showcase nine scientific abstracts at the 2026 ASCO Annual Meeting, May 29–June 2, 2026, in Chicago (booth #32130).

Business Wire • May 26, 2026

Neo Partners with Greenland Mines to Advance Sarfartoq Rare Earth Project

Strategic partnership positions Greenland Mines to lead exploration while Neo retains equity stake and offtake rights Strategic partnership positions Greenland Mines to lead exploration while Neo retains equity stake and offtake rights

GlobeNewsWire • May 20, 2026

Neo Performance Materials Announces C$100 Million Bought Deal Treasury Offering of Common Shares

The base shelf prospectus is accessible, and the prospectus supplement will be accessible within two business days through SEDAR+ The base shelf prospectus is accessible, and the prospectus supplement will be accessible within two business days through SEDAR+

GlobeNewsWire • May 20, 2026

NeoGenomics to Participate in Upcoming Investor Conferences

FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the Company will participate in the following investor conferences: The 23rd Annual Craig-Hallum Institutional Investor Conference in Minneapolis Investor 1x1 meetings on Thursday, May 28th The Jefferies Global Healthcare Conference 2026 in New York Fireside chat on Thursday, June 4th, at 10:30am EDT, and investor 1x1 meetings A w.

Business Wire • May 15, 2026

NeoGenomics, Inc. (NEO) Q1 2026 Earnings Call Transcript

NeoGenomics, Inc. (NEO) Q1 2026 Earnings Call Transcript

Seeking Alpha • Apr 29, 2026

NeoGenomics Reports First Quarter 2026 Results

FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics announced its first-quarter results for the period ended March 31, 2026.

Business Wire • Apr 28, 2026

NeoGenomics Expands Access to Full Oncology Testing Portfolio Through Epic Aura Integration

FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics' oncology testing portfolio is now available through Epic Aura.

Business Wire • Apr 23, 2026